[1] Okahara M，Kiyosue H，Yamashita M，et al.Diagnostic accuracy of magnetic resonance angiography for cerebral aneurysms in correlation with 3D-digital subtration angiographic images：A study of 133 aneurysms. Stroke，2002，33（7）：1803-1808.

[2] Hochmuth A，Spetzger U，Schumacher M.Comparison of three dimensional rotational angiography with digital subtraction angiography in the assessment of ruptured cerebral aneurysms.Am J Neuroradiol，2002，23（7）：1199-1205.

[3] Tanoue S，Kiyosue H，Kenai H，et al.Three dimensional reconstructed images after rotational angiography in the evaluation of intracranial aneurysms：surgical correlation. Neurosurgery，2000，47（4）：866-871.

[4] Strothera CM，Benderb F，Deuerling-Zheng Y，et al. Parametric color coding of digital subtraction angiography. AJNR Am J Neuroradiol，2010，31：919-924.

[5] Grass M，Ktihler T. Proksa R. 3D cone-beam CT reconstroction for circular trajectoties.Phys Med Bid，2000，45（2）：327-347.

[6] Jou LD，Mobemed A，Lee DH，et al.3D rotational digital subtration angiography may underestimate intracranial aneurysms：f i nd-ings form two obtmailar aneurysms.AJNR，2007，28（9）：1690-1692.

[7]吕岩，刘景鑫，朱昆．三维引导路径图技术在临床上的应用．中国医疗设备，2010，25（7）：7.

[8] Intagliata NM，Maitland H，Northup PG，et al. Treating thrombosis in cirrhosis patients with new oral agents：ready or not? Hepatology. 2015；61：738-739.

[9] Qin S，Bai Y，Lim HY，et al. Randomized，multicenter，open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia．J Clin Oncol. 2013；31：3501-3508.

[10] Brandi G，de Rosa F，Agostini V，et al. Metronomic capecitabine in advanced hepatocellular carcinoma patients：a phase Ⅱ study. Oncologist 2013；18：1256-7. 10.1634/theoncologist.2013-0093.

[11] Kudo M，Moriguchi M，Numata K，et al. A randomized，double-blind，placebo-controlled phase Ⅲstudy of S-1 in patients with sorafenib-refractory advanced hepatocellular carcinoma（S-CUBE）J Clin Oncol. 2015；33（Suppl）：abstr 4018.

[12] Kudo M，Okusaka T，Kaneko S，et al. Identification of a high-response patient population to S-1 via predictive enrichment strategy analysis of the S-CUBE phase Ⅲ trial. J Clin Oncol. 2016；34（Suppl 4S）：abstr 229.

[13]康振国，纪卫政，顾俊鹏，等。肝癌射频消融术后联合替吉奥节拍化疗的疗效评价。实用肿瘤学杂志，2016；30（1）：17-22.

[14]桑泽杰，王华明，纪卫政，等。巴塞罗那肝癌分期B期、C期原发性肝癌患者肝动脉灌注化疗栓塞术后长期口服低剂量替吉奥的疗效观察。中国全科医学，2015；（27）：3324-3327.